Karyopharm Therapeutics (KPTI) PT Lowered to $16 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts KPTI Hot Sheet
Price: $1.99 -1.97%
Rating Summary:
11 Buy, 6 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Rating Summary:
11 Buy, 6 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Join SI Premium – FREE
H.C. Wainwright analyst Edward White lowered the price target on Karyopharm Therapeutics (NASDAQ: KPTI) to $16.00 (from $18.00) while maintaining a Buy rating.
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Bank Polska Kasa Opieki S.A. (PEO:PW) (BKPKF) PT Raised to PLN261 at Barclays
- Ajinomoto (2802:JP) (AJINY) PT Raised to JPY7,300 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
